SPONSOR
Canadian Cancer Trials Group
Total Trials
4
Recruiting
4
Phases
Phase 3, Phase 2
Conditions studied: Multiple MyelomaVulvar Squamous Cell CarcinomaHepatocellular CarcinomaCancer Metastatic
Canadian Cancer Trials Group is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Multiple Myeloma, Vulvar Squamous Cell Carcinoma, Hepatocellular Carcinoma, Cancer Metastatic.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Canadian Cancer Trials Group
How many clinical trials has Canadian Cancer Trials Group sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Canadian Cancer Trials Group, of which 4 are actively recruiting participants. These trials cover conditions including Multiple Myeloma, Vulvar Squamous Cell Carcinoma, Hepatocellular Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Canadian Cancer Trials Group research focus on?
Canadian Cancer Trials Group clinical trials span Multiple Myeloma, Vulvar Squamous Cell Carcinoma, Hepatocellular Carcinoma, Cancer Metastatic. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Canadian Cancer Trials Group clinical trial?
To participate in a Canadian Cancer Trials Group trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Canadian Cancer Trials Group trials with current recruitment status updated daily.
Clinical Trials by Canadian Cancer Trials Group
NCT06182774 Phase 3
Recruiting
Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma
Multiple Myeloma
NCT06358469
Recruiting
STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision
Vulvar Squamous Cell Carcinoma
NCT06880523 Phase 2
Recruiting
STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma
NCT06391242 Phase 3
Recruiting
Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases
Cancer Metastatic
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology